IL17RB and ovarian carcinoma: We found that CRL4 was upregulated in ovarian cancer and that knockdown of CRL4 (Cul4A/DDB1) inhibited cell proliferation and migration, and increased apoptosis in cisplatin-resistant ovarian cancer cells.